# Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder

> **NCT00327756** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Mental Health (NIMH)**

## Conditions studied

- Bipolar Affective Disorder
- Depression

## Interventions

- **DRUG:** Coenzyme Q10

## Key facts

- **NCT ID:** NCT00327756
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-05
- **Primary completion:** 2009-05
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2011-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327756, "Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00327756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*